Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway

Idiopathic pulmonary fibrosis (IPF) is a fatal and age-related pulmonary disease. Nintedanib is a receptor tyrosine kinase inhibitor, and one of the only two listed drugs against IPF. Regorafenib is a novel, orally active, multi-kinase inhibitor that has similar targets to nintedanib and is applied...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Mol Sci
Hoofdauteurs: Li, Xiaohe, Ma, Ling, Huang, Kai, Wei, Yuli, Long, Shida, Liu, Qinyi, Zhang, Deqiang, Wu, Shuyang, Wang, Wenrui, Yang, Guang, Zhou, Honggang, Yang, Cheng
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2021
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7922359/
https://ncbi.nlm.nih.gov/pubmed/33671452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22041985
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items